Gritstone bio, Inc. , a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases.
Gritstone Bio stock last closed at $0.96, up 10.69% from the previous day, and has decreased 61.17% in one year. It has underperformed other stocks in the Biotechnology industry by 0.43 percentage points. Gritstone Bio stock is currently +43.3% from its 52-week low of $0.67, and -71.08% from its 52-week high of $3.33.
At the moment, there are 98.07M shares of GRTS outstanding. The market value of GRTS is $94.44M. In the past 24 hours, 4.19M GRTS shares were traded.
How to Buy Gritstone Bio Stock
Wondering how to invest in Gritstone Bio stock? Here's how.
Choose where to buy Gritstone Bio stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Gritstone Bio stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Put funds into your brokerage account: Choose your method of payment and add your details.
Research Gritstone Bio stock: The Gritstone Bio ticker symbol is GRTS. Is Gritstone Bio stock a good investment? Should you buy shares of GRTS? How do GRTS's underlying business fundamentals look? Do top analysts think Gritstone Bio is a good buy? Why has GRTS's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if GRTS is a good stock to buy).
Make your GRTS trade: Decide if you will purchase GRTS shares at the current market price or use a limit order to buy GRTS stock at a given price.
Keep tabs on your GRTS investment: Create a watchlist to monitor your new investment in Gritstone Bio shares.
Step 1: Choose where to buy Gritstone Bio stock
You will need a brokerage account in order to access the NASDAQ market and buy GRTS shares.
A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world financial markets: From Tech to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal info so you can buy GRTS today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Gritstone Bio stock
Once you have chosen the best place to buy Gritstone Bio stock, it's very important to analyze their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
Gritstone Bio quick stats
GRTS Price
$0.96
1w %
18.45%
1y %
-61.17%
5y %
-91.04%
P/E
-0.8x
P/B
1.82x
P/S
6.83x
PEG
N/A
Revenue
$16.34M
Earnings
-$138.49M
Fore. Rev. Growth
73.24%
Fore. Earn. Growth
N/A
Market Cap
$94.44M
Next Earnings
Jun 17, 2024
Next Dividend
N/A
Gritstone Bio Zen Score
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis.
Last year, GRTS revenue was $16.34M. Over the last five year, GRTS's revenue has grown by 68.96% per year. This was faster than the Biotechnology industry average of 29.63%.
In the last year, executives and large shareholders at GRTS have bought more shares than they have sold.
Vassiliki Economides, Executive Vice President Chief Financial Officer of GRTS, was the latest GRTS insider to buy. They bought $22,824.00 worth of GRTS shares on May 23, 2023.
No, Gritstone Bio doesn't provide an income stream by paying out dividends.
What do other investors have to say about GRTS?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your GRTS trade
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are generally sufficient.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Click the Open button and your broker will execute your order.
If you need additional info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Gritstone Bio share?
As of May 3, 2024, it costs $0.96 to buy one share of Gritstone Bio stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.48, you can buy 0.5 shares of GRTS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.